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Objectives: To determine the utility of routine post-
operative troponin (PO Tn) measurements in patients
undergoing major vascular surgical reconstructions
(VSRs).
Methods: Data from consecutive patients under-
going VSRs and routine PO Tn measurement over one
year, January 1 to December 31, 2010, were retrospec-
tively analyzed. A positive troponin (Tn) panel included
a baseline level immediately after the procedure of $
.20 ng/mL, or a delta at 3 and/or 6 hours of $ .30
ng/mL/$ 20%. Patients without complete Tn panels
and research authorization were excluded. Cox Propor-
tional hazards model was used to evaluate the effect of
preoperative risk factors and postoperative Tn levels on
early and mid-term mortality.
Results: Of 725 patients undergoing VSRs 678 (462
males, 216 females; mean age 69 years) satisﬁed criteria
for inclusion. Procedures included 408 open, 196 endovas-
cular and 73 hybrid (306 abdominal, 197 infrainguinal, 40
thoracoabdominal, 117 cerebrovascular and 18 upper
extremity). Tn levels were elevated in 67 patients (10%;
M: 42, F: 25) and after consultation with a cardiologist
were ascribed to non-ST elevation myocardial infarction
(NSTEMI) in 26, STEMI in six, demand ischemia in 29
and renal insufﬁciency in six. Sixty-one patients were
managed medically; six underwent cardiac catheterization
and intervention. Thirty-day mortality was signiﬁcantly
higher in Tn+ compared to Tn- patients (7.6% vs 1.7%; P
¼ .08). On multivariate analysis abnormal delta Tn (P ¼
.008; HR, 2.0; 95% CI, 1.2-3.4) and SVS/AAVS co-
morbidity score >9 were associated with mortality. The
cumulative probability of death in Tn+ patients remained
signiﬁcantly higher at 1 (27.6% vs 10.6%; P ¼ .004) and
2 years (40.8% vs 18.5%; P ¼ .002).
Conclusions: Elevated delta troponin levels following
major vascular surgical procedures are independently asso-
ciated with higher 30 day and mid-term mortality, and this
marker should be considered an important prognostic
indicator.
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Predictors of Access-Site Related Complications After
Lower Extremity Percutaneous Revascularization
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Objectives: Though well described in the cardiology
literature, less is known about risks for access site-related
complications (ASC) following percutaneous lower extremity
revascularization. We also sought to evaluate the beneﬁt of
routine ultrasound-guided access (RUS) in decreasing ASC.
Methods: We reviewed all percutaneous revasculari-
zations (PTA or stent) performed for lower extremity
atherosclerosis at our institution from 2002-2012.
RUS began October 2007. Primary outcome was any
ASC (bleeding, groin or retroperitoneal [RP]
hematoma, vessel rupture, or thrombosis). Multivariable
logistic regression was used to determine predictors of
ASC.
Results: A total of 1419 punctures were performed on
925 patients (43% women, median age 69 [IQR 60-78]
years for claudication (30%), critical limb ischemia (58%),
or other (12%) using 4-8Fr sheaths. 76 ASC occurred
(5.4%): 15 instances of bleeding, 41 groin & 8 RP hema-
toma, two artery ruptures, nine pseudoaneurysms, & one
thrombosis. CT evaluation was done in 13, thrombin injec-
tion in nine, and operative repair in 20 patients. ASC were
more common before RUS (7.6% vs 4.5%; P ¼ .026).
Multivariable predictors of ASC were older age, preopera-
tive warfarin use, & procedure performance before RUS
(Table). Vascular closure devices (VCD) were not associ-
ated with ASC rates but when attempted, failures were
associated with a higher ASC rate (15% vs 4%; P ¼ .006).
Conclusions: RUS has decreased ASC in recent years
but VCD have not demonstrated a signiﬁcant impact.
Particular care should be taken on patients >75 years old
& those on warfarin preoperatively.Table. Multivariable predictors of ASC
Odds ratio 95% CI P valueAge
<65 years - - -
65-74 years 1.65 0.81-3.33 .167
75+ years 2.37 1.27-4.42 .006
Pre operative warfarin use 2.46 1.44-4.19 .001
VCD vs manual compression 0.64 0.37-1.13 .124
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